Stay updated on Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.

Latest updates to the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page
- Check7 days agoChange DetectedThe page footer’s revision label was updated from v3.6.3 to v3.6.4, signaling a small template update used for rendering the Record History.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe Record History page shows Revision: v3.6.3 as the latest version, replacing v3.6.2, indicating a system or UI update to the page rather than a modification to trial information. This reflects an internal update and does not alter the study data or its presentation.SummaryDifference0.0%

- Check35 days agoChange DetectedThe revision label at the bottom of the page has changed from v3.6.0 to v3.6.2, indicating an updated site build. This update affects metadata display rather than the study data or history entries.SummaryDifference0.0%

- Check50 days agoChange DetectedRecruitment for the study has ceased, as indicated by the addition 'No longer looking for participants.' The record also updates to revision v3.6.0, superseding the previous v3.5.5 revision.SummaryDifference0.2%

- Check57 days agoChange DetectedRevision: v3.5.5 is now displayed on the page, replacing Revision: v3.5.4, indicating a newer page revision rather than substantive changes to the trial record.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.5.4 was added to the page history, replacing v3.5.3 and indicating a new site build/deployment.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.